KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Common Equity (2016 - 2025)

Unitedhealth (UNH) has disclosed Common Equity for 17 consecutive years, with $100.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 1.85% to $100.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $100.1 billion, a 1.85% increase, with the full-year FY2025 number at $100.1 billion, up 1.85% from a year prior.
  • Common Equity was $100.1 billion for Q4 2025 at Unitedhealth, down from $101.6 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $101.6 billion in Q3 2025 to a low of $69.3 billion in Q1 2021.
  • A 5-year average of $87.3 billion and a median of $88.5 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: rose 15.93% in 2023, then grew 1.69% in 2025.
  • Unitedhealth's Common Equity stood at $75.0 billion in 2021, then increased by 8.53% to $81.4 billion in 2022, then rose by 15.93% to $94.4 billion in 2023, then rose by 4.07% to $98.3 billion in 2024, then rose by 1.85% to $100.1 billion in 2025.
  • Per Business Quant, the three most recent readings for UNH's Common Equity are $100.1 billion (Q4 2025), $101.6 billion (Q3 2025), and $100.5 billion (Q2 2025).